Vironix Health· news · 1 min read
RPM Reimbursements Are Evolving
 (1).BcphoKDt.png)
Remote Patient Monitoring (RPM) is scaling rapidly, but reimbursement frameworks risk lagging behind evidence.
A policy analysis from the Peterson Center on Healthcare urges CMS and policymakers to shift from “pay-for-activity” to pay-for-performance in RPM — meaning reimbursement should reward demonstrated clinical benefit, not just data collection alone.
To put it in context: Medicare’s spending on RPM has exploded. In one published report, total Medicare outlays for RPM grew from $15 million in 2019 to over $300 million in 2022.
Another striking statistic: by 2025, it’s estimated that 71 million Americans (roughly 26% of the population) will use some form of RPM.
But the upside is not just volume — it’s margins. Some practices report that for every 100 RPM-enrolled patients, Medicare reimbursements increase by ~$100,000 annually.
Still, this growth invites risk: audit exposure, uncertainty around “forever codes,” and creeping regulatory scrutiny.
At Vironix Health, we’re building our RPM stack not just for scale, but for defensibility, which looks like rigorous outcomes, strong audit trails, and alignment with what payers and regulators will increasingly demand.
What performance metric or clinical outcome do you think should be tied to RPM reimbursement first?
SOURCES
https://intuitionlabs.ai/articles/remote-patient-monitoring-united-states-2025-landscape
https://medifyhealth.com/wp-content/uploads/2025/01/2024-12_Medify_2025-RPM-Regulations.pdf